Document Preview Unavailable
Delayed inflammation decrease is associated with mortality in Tocilizumab-treated critically ill SARS-CoV-2 patients: A retrospective matched-cohort analysis
Urbina Tomas; Jean-Rémi, Lavillegrand; Garnier, Marc; Mekinian Arsene; Pacanowski Jerome; et al. Innate Immunity Vol. 28, Iss. 1, (Jan 2022): 3-10.You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library